Aldosterone reduction during 24 weeks of treatment with aliskiren or placebo added to losartan in patients with type 2 diabetes and nephropathy, an AVOID substudy

Category Primary study
ConferenceDiabetologia
Year 2010
This article has no abstract
Epistemonikos ID: 0e5d2683b00f84df5950521d04e1d89815b5320d
First added on: Apr 30, 2026